Compass Therapeutics (CMPX) Cash & Equivalents (2018 - 2026)
Compass Therapeutics (CMPX) posted Cash & Equivalents of $36.02 million for Q2 2026, up 53.8% from $23.42 million a year earlier but down 35.4% from the prior quarter.
Compass Therapeutics (CMPX) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Compass Therapeutics' Cash & Equivalents came in at $31.21 million, down 29.1% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
- In prior years, Compass Therapeutics' Cash & Equivalents was $44.05 million in FY2024 (+81.8%), $24.23 million in FY2023 (-30.7%), $34.95 million in FY2022 (-75.8%) and $144.51 million in FY2021 (+207.0%).
- Quarterly Cash & Equivalents has run from a low of $16.48 million in Q3 2022 to a high of $144.51 million in Q4 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 25.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 243.6%; the weakest was Q1 2023, with a decline of 80.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $55.74 million (Q1 2026), $31.21 million (Q4 2025) and $46.78 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Compass Therapeutics | 187.29 Mn | 187.29 Mn | - | 36.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.02 Mn |
| Mar 31, 2026 | 55.74 Mn |
| Dec 31, 2025 | 31.21 Mn |
| Sep 30, 2025 | 46.78 Mn |
| Jun 30, 2025 | 23.42 Mn |
| Mar 31, 2025 | 41.62 Mn |
| Dec 31, 2024 | 44.05 Mn |
| Sep 30, 2024 | 37.37 Mn |
| Jun 30, 2024 | 19.40 Mn |
| Mar 31, 2024 | 43.48 Mn |
| Dec 31, 2023 | 24.23 Mn |
| Sep 30, 2023 | 30.43 Mn |
| Jun 30, 2023 | 19.28 Mn |
| Mar 31, 2023 | 27.03 Mn |
| Dec 31, 2022 | 34.95 Mn |
| Sep 30, 2022 | 16.48 Mn |
| Jun 30, 2022 | 26.24 Mn |
| Mar 31, 2022 | 136.40 Mn |
| Dec 31, 2021 | 144.51 Mn |
| Sep 30, 2021 | 25.51 Mn |
Compass Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMPX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CMPX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMPX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();